Martin James Whitaker
Directeur/Membre du Conseil chez D3 Pharma Ltd
Profil
Martin James Whitaker is the founder of Faveo Ltd.
He currently holds director positions at Diurnal Ltd.
and D3 Pharma Ltd.
Previously, he was the Chief Executive Officer & Executive Director at Diurnal Group Ltd.
from 2012 to 2022.
He also held positions as Operations Director at Critical Pharmaceuticals Ltd., Business Manager at Fusion IP Ltd., and Head-Research & Development at Pfizer Ltd.
Additionally, he served as a Non-Executive Director at PH Therapeutics Ltd.
from 2013 to 2014.
Whitaker received his undergraduate degree from the University of Bristol and his doctorate from The University of Nottingham.
Postes actifs de Martin James Whitaker
| Sociétés | Poste | Début |
|---|---|---|
| D3 Pharma Ltd | Directeur/Membre du Conseil | - |
Diurnal Ltd.
 Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Part of Neurocrine Biosciences, Inc., Diurnal Ltd. is a European, British UK-headquartered specialty pharmaceutical company founded in 2004. The company is based in Cardiff, UK. The company is dedicated to developing lifelong treatments for rare and chronic endocrine conditions. | Directeur/Membre du Conseil | 22/08/2012 |
Anciens postes connus de Martin James Whitaker
| Sociétés | Poste | Fin |
|---|---|---|
| DIUL GROUP | Directeur Général | 04/04/2022 |
PH Therapeutics Ltd.
 PH Therapeutics Ltd. Medical/Nursing ServicesHealth Services PH Therapeutics Ltd. engages in the research and development of biological treatments. It develops novel antibody therapies to treat the orphan disease Pulmonary Arterial Hypertension. The company was founded in 2013 by Allan Lawrie and is headquartered in Leeds, the United Kingdom. | Directeur/Membre du Conseil | 03/07/2014 |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Faveo Ltd.
 Faveo Ltd. Apparel/FootwearConsumer Non-Durables Faveo Ltd. designed and manufactured backless and strapless bra. The company was founded by Joanne Lynsey Morgan in 2004 and was headquartered in Tamworth, the United Kingdom. | Fondateur | - |
| FUSION IP PLC | Corporate Officer/Principal | - |
Formation de Martin James Whitaker
| University of Bristol | Undergraduate Degree |
| The University of Nottingham | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Fusion IP Ltd.
 Fusion IP Ltd. Miscellaneous Commercial ServicesCommercial Services Fusion IP Ltd. operates as a holding company. It engages in the commercialization of intellectual properties that is developed at universities and similar establishments. The company was founded by Peter Leonard Grant, Stewart Gall and David Graham Baynes in 2002 and is headquartered in Sheffield, the United Kingdom. | Commercial Services |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Health Technology |
Critical Pharmaceuticals Ltd.
 Critical Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Critical Pharmaceuticals Ltd. operates as a clinical stage biotechnology company with interest in developing and producing biological drug products. The company product pipeline includes CP024: Nasal hGH, CP046: Nasal PTH, CP016: hGH Depot and CP018: Risperidone. Critical Pharmaceuticals was founded by Steve Howdle and Kevin Morris Shakesheff in 2002 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Diurnal Group Ltd.
 Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Diurnal Group plc engages in the development of products for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. It focuses on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
PH Therapeutics Ltd.
PH Therapeutics Ltd. Medical/Nursing ServicesHealth Services PH Therapeutics Ltd. engages in the research and development of biological treatments. It develops novel antibody therapies to treat the orphan disease Pulmonary Arterial Hypertension. The company was founded in 2013 by Allan Lawrie and is headquartered in Leeds, the United Kingdom. | Health Services |
Diurnal Ltd.
Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Part of Neurocrine Biosciences, Inc., Diurnal Ltd. is a European, British UK-headquartered specialty pharmaceutical company founded in 2004. The company is based in Cardiff, UK. The company is dedicated to developing lifelong treatments for rare and chronic endocrine conditions. | Health Technology |
| D3 Pharma Ltd | |
Faveo Ltd.
Faveo Ltd. Apparel/FootwearConsumer Non-Durables Faveo Ltd. designed and manufactured backless and strapless bra. The company was founded by Joanne Lynsey Morgan in 2004 and was headquartered in Tamworth, the United Kingdom. | Consumer Non-Durables |
